跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
盧 俊良
教授
腦科學研究所
電話
02-28712111#3385
電子郵件
cllu
vghtpe.gov
tw
h-index
h10-index
h5-index
4652
引文
39
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
877
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
272
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1993 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(181)
類似的個人檔案
(6)
指紋
查看啟用 Ching-Liang Lu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Irritable Bowel Syndrome
100%
Taiwan
92%
Asia
42%
Stomach
37%
Hepatocellular Carcinoma
33%
Gastric Emptying
31%
Peptic Ulcer Disease
28%
Helicobacter Pylori (H. pylori)
26%
Risk Factors
25%
Chronic Hepatitis C
25%
Total Gastrectomy
24%
Functional Dyspepsia
24%
Motility
23%
Slow Wave
22%
Gastric Myoelectrical Activity
22%
Dominant Frequency
22%
Cirrhotic Patients
22%
Solid Gastric Emptying
19%
Erosive Esophagitis
19%
Rome II
19%
Gastrointestinal Transit
18%
Electrogastrography
17%
Myoelectricity
17%
Orocecal Transit Time
17%
Cirrhosis
16%
Diarrhea-predominant Irritable Bowel Syndrome
16%
Duodenal Ulcer
16%
Visceral Hypersensitivity
16%
Chinese Population
15%
Proton Pump Inhibitors
15%
Chronic Pancreatitis
15%
Omeprazole
14%
Teamwork
14%
Social Impact
14%
Functional Gastrointestinal Disorders
14%
Functional Constipation
14%
Oriental Studies
14%
Spinal Microglia
14%
Gastric Epithelial Cells
14%
Rome Foundation
14%
Inflammatory Bowel Disease
14%
Chinese Patients
14%
Power Ratio
13%
Peptic Ulcer
13%
Helicobacter Pylori Infection
13%
Hepatocellular Carcinoma Patients
13%
Gastrointestinal Motility
13%
Acute Pancreatitis
13%
Odds Ratio
12%
Asian Patients
12%
Medicine and Dentistry
Irritable Bowel Syndrome
77%
Stomach Acid
38%
Hepatocellular Carcinoma
30%
Helicobacter Pylori
28%
Stomach Emptying
25%
Chronic Hepatitis C
23%
Prevalence
23%
Jejunum Ulcer
22%
Gastrectomy
21%
Electrogastrogram
21%
Hepatic Encephalopathy
20%
Liver Cirrhosis
20%
Functional Gastrointestinal Disorder
19%
Hepatitis B Virus
19%
Gastroesophageal Reflux
18%
Proton-Pump Inhibitor
18%
Neoplasm
18%
Constipation
17%
Diagnosis
17%
Reflux Esophagitis
14%
Chronic Pancreatitis
14%
Abdominal Cancer
14%
Sleep Quality
14%
Acute Pancreatitis
14%
Microglia
14%
Inflammatory Bowel Disease
13%
Food Intake
13%
Visceral Pain
13%
Bleeding
13%
Colonoscopy
13%
Odds Ratio
12%
Myoelectricity
12%
Gastrointestinal Motility
12%
Heartburn
12%
Hyperpathia
11%
Diseases
11%
Surgery
11%
Hepatitis C Virus
10%
Chronic Hepatitis B
10%
Appendicitis
10%
Functional Constipation
10%
Diarrhea
10%
Placebo
10%
Duodenum Ulcer
10%
Hepatitis B
9%
Ulcer
9%
Body Mass Index
9%
Endoscope
9%
Inferior Vena Cava
9%
Interleukin 6
9%
Pharmacology, Toxicology and Pharmaceutical Science
Irritable Colon
76%
Prevalence
21%
Liver Cell Carcinoma
21%
Hepatitis B Virus
20%
Helicobacter Pylori
19%
Chronic Hepatitis C
19%
Stomach Acid
18%
Jejunum Ulcer
17%
Peptic Ulcer
17%
Liver Cirrhosis
16%
Gastroesophageal Reflux
15%
Reflux Esophagitis
14%
Dexamethasone
14%
Hepatic Encephalopathy
14%
Placebo
13%
Diarrhea
12%
Ulcer
11%
Neoplasm
11%
Duodenum Ulcer
11%
Chronic Hepatitis B
10%
Normal Human
10%
Acetylsalicylic Acid
10%
Omeprazole
10%
Diseases
10%
Clopidogrel
9%
Chronic Pancreatitis
9%
Inflammatory Bowel Disease
9%
Cholelithiasis
9%
Growth Factor
9%
Esophageal Adenocarcinoma
9%
Lactic Acid
9%
Adenocarcinoma
9%
Stomach Ulcer
9%
Hepatitis C Virus
9%
Hepatitis B
8%
Constipation
8%
Hepatitis C
8%
Cohort Study
7%
Ulcer Healing
7%
Hepatitis B Antigen
7%
Endothelin 1
7%
Cyclooxygenase 2
7%
Digestive System Function Disorder
7%
Sleep Disorder
7%
Receptor
7%
Esophageal Squamous Cell Carcinoma
7%
Polyp
7%
Proton Pump Inhibitor
6%
Heartburn
6%
Rat Model
6%
